IRIS
DEROSA, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.673
AS - Asia 18.555
EU - Europa 14.074
SA - Sud America 2.423
AF - Africa 564
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 20
Totale 57.345
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.184
CN - Cina 10.032
SG - Singapore 3.944
IE - Irlanda 2.942
UA - Ucraina 2.534
DE - Germania 2.071
BR - Brasile 1.805
FI - Finlandia 1.686
HK - Hong Kong 1.670
VN - Vietnam 1.350
RU - Federazione Russa 1.226
IT - Italia 1.043
FR - Francia 808
SE - Svezia 804
GB - Regno Unito 490
IN - India 350
ZA - Sudafrica 268
CA - Canada 266
AR - Argentina 198
BD - Bangladesh 193
IQ - Iraq 154
MX - Messico 124
EC - Ecuador 107
NL - Olanda 107
TR - Turchia 103
JP - Giappone 98
ID - Indonesia 84
PK - Pakistan 81
CO - Colombia 73
VE - Venezuela 68
MA - Marocco 64
UZ - Uzbekistan 56
ES - Italia 54
PH - Filippine 54
CL - Cile 48
PL - Polonia 48
EG - Egitto 47
SA - Arabia Saudita 46
MY - Malesia 44
TN - Tunisia 42
KE - Kenya 40
PE - Perù 39
JO - Giordania 36
PY - Paraguay 35
IR - Iran 32
BE - Belgio 31
RO - Romania 26
BO - Bolivia 24
IL - Israele 22
LT - Lituania 22
GR - Grecia 21
AE - Emirati Arabi Uniti 20
AL - Albania 20
KZ - Kazakistan 20
TH - Thailandia 20
AZ - Azerbaigian 19
CH - Svizzera 19
NP - Nepal 19
UY - Uruguay 19
AT - Austria 18
CR - Costa Rica 18
DZ - Algeria 18
ET - Etiopia 18
MU - Mauritius 18
NZ - Nuova Zelanda 16
AU - Australia 15
DO - Repubblica Dominicana 15
EU - Europa 15
JM - Giamaica 15
PA - Panama 15
CZ - Repubblica Ceca 14
KG - Kirghizistan 14
BH - Bahrain 12
NI - Nicaragua 12
MK - Macedonia 11
PT - Portogallo 11
SN - Senegal 11
OM - Oman 9
QA - Qatar 9
RS - Serbia 9
KR - Corea 8
KW - Kuwait 8
AM - Armenia 7
HN - Honduras 7
MD - Moldavia 7
TT - Trinidad e Tobago 7
BG - Bulgaria 6
CI - Costa d'Avorio 6
GE - Georgia 6
HU - Ungheria 6
LV - Lettonia 6
DK - Danimarca 5
LB - Libano 5
LK - Sri Lanka 5
XK - ???statistics.table.value.countryCode.XK??? 5
BA - Bosnia-Erzegovina 4
BY - Bielorussia 4
EE - Estonia 4
LA - Repubblica Popolare Democratica del Laos 4
SI - Slovenia 4
Totale 57.257
Salva come PNG Salva come JPEG
Città #
Jacksonville 3.395
Dublin 2.942
Chandler 2.846
Nanjing 2.513
San Jose 1.929
Singapore 1.855
Hong Kong 1.623
Dallas 1.544
Ashburn 1.515
Boardman 1.097
Nanchang 1.092
Beijing 960
Princeton 807
Shenyang 768
Hebei 702
Lawrence 700
Changsha 684
Wilmington 655
Lauterbourg 633
Jiaxing 575
Munich 537
Medford 521
Ho Chi Minh City 463
Los Angeles 445
Hangzhou 433
Tianjin 426
Helsinki 419
Hanoi 339
Redondo Beach 302
Buffalo 269
Johannesburg 229
Moscow 203
Milan 194
São Paulo 178
New York 175
Shanghai 144
Toronto 144
Ann Arbor 138
Seattle 120
Woodbridge 115
Norwalk 111
Santa Clara 95
Tokyo 89
Fairfield 78
Jinan 77
Turku 77
Orem 72
Baghdad 70
Frankfurt am Main 69
Kunming 69
Des Moines 68
Da Nang 63
Guangzhou 60
Rio de Janeiro 58
Chennai 57
Brooklyn 56
Cambridge 55
Montreal 54
Quito 53
Ningbo 52
Haiphong 51
Pavia 50
San Francisco 50
Dhaka 49
Tashkent 49
Zhengzhou 46
London 43
Verona 43
Chicago 42
Pune 37
Stockholm 36
Warsaw 36
Nairobi 33
Rome 33
Atlanta 32
Belo Horizonte 32
Guayaquil 32
Amman 30
Campinas 30
Council Bluffs 30
Orange 30
Phoenix 30
Biên Hòa 29
Boston 28
Brussels 28
Mumbai 28
Lahore 27
Brasília 26
Hải Dương 26
New Delhi 25
Poplar 25
Curitiba 24
Eindhoven 24
Mexico City 24
Charlotte 23
Falkenstein 23
Nuremberg 23
Salvador 23
Casablanca 22
Bắc Ninh 21
Totale 37.305
Salva come PNG Salva come JPEG
Nome #
Effetto del lactobacillus paracasei I1688 e del lactobacillus salivarius I1794 (psmix®) sui lipidi ematici nell’ipercolesterolemia lieve 365
Impaired respiratory function reduces haemoglobin oxygen affinity in COVID-19 321
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 289
Anemia in patients with Covid-19: pathogenesis and clinical significance 286
Atorvastatin addition to losartan or to atenolol and recurrence of paroxysmal atrial fibrillation in hypertension 248
Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical Trial 242
A randomized, placebo-controlled study about the effect of a nutraceutical combination of red yeast rice, silybum marianum and octasonol on lipid profile, endothelial and inflammatory parameters 198
Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial 182
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 172
A possible way to improve the glycemic control and the beta cell function during three years: the triple therapy. 154
Correction to: Anemia in patients with Covid-19: pathogenesis and clinical significance (Clinical and Experimental Medicine, (2021), 10.1007/s10238-020-00679-4) 153
A multicenter, randomised, single-blind study on the effects of exenatide or glimepiride on insulin resistance. 150
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 149
A comparison between sitagliptin or glibenclamide in addition to metformin+pioglitazone on glycemic control and beta-cell function: the triple oral therapy 142
Abscisic Acid Treatment in Patients with Prediabetes. 139
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 136
A nutraceutical based approach to reduce cholesterolaemia in patients previously intolerant of more than a statin: a pilot study 130
A review about biomarkers for the investigation of vascular function and impairment in diabetes mellitus 130
A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients 129
Association between low-molecular weight apolipoprotein(a) isoforms and obesity in Italian women 129
Different actions of losartan and ramipril on adipose tissue Activity and vascular remodeling biomarkers in hypertensive patients 129
Adipocytokines levels in obese and non-obese subjects, an observational study 129
A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome 129
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 128
Confronto tra nateglinide più metformina rispetto a glibenclamide più metformina sul metabolismo glucidico nei pazienti diabetici di tipo 2: studio ad 1 anno 128
Diagnostico y Tratamiento de los desordenes lipidicos. Mc Graw Hill Education 2014. 127
A systematic reviewandmeta-analysis of randomized controlled trials investigating the effects of supplementationwith Nigella sativa (black seed) on blood pressure 127
A randomized, double blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parameters and β-cell function. 126
A randomized, double blind, comparative therapy evaluating sitagliptin versus glibenclamide in type 2 diabetic patients already treated with pioglitazone and metformin: a three years study 126
Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study 125
Comparison between diet, orlistat and fluvastatin in obese patients with mild hypertension and hypercholesterolemia 125
Confronto tra pioglitazone e rosiglitazone sul metabolismo glucidico e lipidico nei soggetti diabetici di tipo 2 in terapia con metformina 125
Atorvastatin-amlodipine combination and fibrinolytic balance in hypertensive hypercholesterolemic insulin-resistent patients 125
Differential effect of glimepiride and rosiglitazone on metabolic control of type 2 diabetic patients treated with metformin: a randomized, double-blind, clinical trial 123
Effect of valsartan or olmesartan addition to amlodipine/hydrochlorotiazide combination on 24 hour blood pressure reduction in essential hypertension 123
Azione della moxonidina sul metabolismo glucidico e lipidico negli ipertesi con sindrome metabolica 123
A comparison study of Lp(a) plasma levels distribution between normo and hypertensive subjects with high BMI 123
Diarrea in paziente diabetico 123
Confronto tra dieta, orlistat e fluvastatina in soggetti obesi, con ipertensione arteriosa lieve e ipercolesterolemia 122
Confronto tra candesartan e olmesartan sui parametri correlati alla sensibilità insulinica nei pazienti ipertesi con diabete mellito di tipo 2 122
Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load 120
Effect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuria 119
Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes 119
Differential effect of candesartan and olmesartan on adipose tissue activity biomarkers in type 2 diabetic hypertensive patients 119
Effetti di pioglitazone e rosiglitazone nei pazienti con diabete di tipo 2 e sindrome metabolica trattati con metformina 119
Actions of glimepiride plus metformin compared to rosiglitazone plus metformin on glucose metabolism, fibrinolytic, and coagulation measurements in Type 2 diabetic patients. 119
Comparison between orlistat and sibutramine in obese patients with mild hypertension 117
Matrix metalloproteinase 2 may be a marker of microangiopathy compared to metalloproteinase 9 in children and adolescents with type 1 diabetes mellitus: A 5 year follow-up study 117
Effects of combination of sibutramine and L-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients 117
A clinical trial about a food supplement containing α-lipoic acid on oxidative stress markers in type 2 diabetic patients 116
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia 115
Acarbose compared to placebo on insulin resistance biomarkers in a double-blind, placebo-controlled trial 115
Effetti metabolici di telmisartan e irbesartan nei pazienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone 115
A randomized, double-blind clinical trial on the long term efficacy of psyllium husk vs. guar gum on the clinical features of metabolic syndrome 115
Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients 114
Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial 114
Comparative effects of telmisartan and eprosartan on insulin sensitivity in the treatment of overweight hypertensive patients 113
Atorvastatin addition to losartan or to atenolol and recurrence of paroxysmal atrial fibrillation in hypertension 113
A curious case of hypoglycaemia 112
Effects of berberis aristata/silybum marianum association on metabolic parameters and adipocytokines in overweight dyslipidemic patients 112
A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular risk 112
Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome 111
Aliskiren reduces QT dispersion in hypertensive diabetic patients 111
Comparison between exenatide and glimepiride on metabolic control and on insulin resistance in type 2 diabetic patients with metformin therapy 110
Comparison between glimepiride plus pioglitazone vs. glimepiride plus rosiglitazone on glucose metabolism and on lipid, lipoprotein and apolipoprotein fractions in type 2 diabetic patients 110
Different aspects of sartan + calcium antagonist association compared to the single therapy on inflammation and metabolic parameters in hypertensive patients 110
n-3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia 110
Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome 109
Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus 108
Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients 108
Matrix metalloproteinase-2 activity (MMP-2) in children and adolescents with type 1 diabetes mellitus: Follow-up study 108
Differenti effetti di candesartan e olmesartan sui parametri di attività del tessuto adiposo in pazienti diabetici di tipo 2 ipertesi 108
Variation of inflammatory parameters after sibutramine treatment compared to placebo in type 2 diabetic patients 107
Effetti di un anno di trattamento con vildagliptin associato a pioglitazone o glimepiride in pazienti diabetici scarsamente controllati 107
Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone 106
Comparison between fosinopril and eprosartan on lipid profile and Lp(a) in normotensive, type 2 diabetic subjects, with microalbuminuria 106
Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses. 106
Comparison between orlistat and sibutramine in obese patients with type 2 diabetes mellitus 106
A Randomized, Double-Blind, Controlled, Parallel-Group Comparison of Perindopril and Candesartan in Hypertensive Patients with Type 2 Diabetes Mellitus 106
Effects of sibutramine plus L-carnitine compared to sibutramine on inflammatory parameters in type 2 diabetic patients 105
Changes during glimepiride plus rosiglitazone vs glibenclamide plus rosiglitazone treatment on glucose metabolism and lipoprotein (a) in Type 2 diabetic patients. 105
The efficacy and safety of pioglitazone or rosiglitazone added onto metformin in type 2 diabetes patients with metabolic syndrome 105
Effect of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic insulin-resistant patients 105
Metalloproteasi-2, metalloproteasi-9 ed inibitore tissutale delle metalloproteasi-1 in pazienti ipertesi 104
Azione della moxonidina sul metabolismo glucidico e lipidico negli ipertesi con sindrome metabolica 104
n-3 PUFAs on metalloproteinases, inflammatory and insulin resistance parameters in dyslipidemic patients after euglycemic clamp and oral fat load. 104
Lipoprotein (a) Particles Characterization by Dynamic Light Scattering 104
Doxazosin improves blood pressure and metabolic parameters in impaired glucose tolerance patients in therapy with acarbose 104
Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation 103
Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients 103
Effetti di un anno di trattamento con orlistat+L-carnitina paragonato a orlistat o placebo sui parametri di insulino-resistenza nei pazienti diabetici 103
Berberis aristata/silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patients 103
Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study 103
High Lp(a) levels and atherogenic isoforms in patients with acute coronary sindrome 102
Effetti metabolici di telmisartan e di irbesartan in pazienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone: un trial clinico randomizzato a doppio cieco 102
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 102
Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus 102
COVID-19 pandemic impact on people with diabetes: results from a large representative sample of Italian older adults 101
Effects of rosiglitazone alone and in association with simvastatin on lipid and lipoprotein parameters in patients with metabolic syndrome 101
Effetti dell'associazione tra pioglitazone e sibutramina sul metabolismo glucidico e lipidico nei soggetti obesi diabetici di tipo 2 101
Totale 12.897
Salva come PNG Salva come JPEG
Categoria #
all - tutte 234.166
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 234.166
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.487 0 0 0 0 0 0 0 0 0 729 628 130
2021/20222.603 28 7 124 17 11 13 30 162 135 45 480 1.551
2022/20238.600 942 532 47 615 1.009 917 7 537 3.523 96 259 116
2023/20242.641 259 500 95 195 353 653 65 256 28 84 61 92
2024/20258.112 76 807 270 280 146 262 689 756 1.743 123 781 2.179
2025/202616.968 1.383 1.355 2.313 2.041 1.850 777 3.783 786 1.563 1.117 0 0
Totale 57.936